FINWIRES · TerminalLIVE
FINWIRES

Update: Mizuho Securities Keeps Price Target on Apellis Pharmaceuticals to $41, Maintains Neutral Rating

作者

-- (Updated to keep price target unchanged).

Apellis Pharmaceuticals (APLS) has an average rating of hold and mean price target of $40.82, according to analysts polled by FactSet.

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

Price: $40.95, Change: $-0.05, Percent Change: -0.11%

相关文章